Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Human Papillomavirus Vaccine Effectiveness Against HPV Infection: Evaluation of One, Two, and Three Doses.

Markowitz LE, Naleway AL, Klein NP, Lewis RM, Crane B, Querec TD, Hsiao A, Aukes L, Timbol J, Weinmann S, Liu G, Steinau M, Unger ER.

J Infect Dis. 2019 Nov 30. pii: jiz555. doi: 10.1093/infdis/jiz555. [Epub ahead of print]

PMID:
31784749
2.

Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine.

Donahue JG, Kieke BA, Lewis EM, Weintraub ES, Hanson KE, McClure DL, Vickers ER, Gee J, Daley MF, DeStefano F, Hechter RC, Jackson LA, Klein NP, Naleway AL, Nelson JC, Belongia EA.

Pediatrics. 2019 Dec;144(6). pii: e20191808. doi: 10.1542/peds.2019-1808. Epub 2019 Nov 18.

PMID:
31740498
3.

Uptake and safety of hepatitis A vaccination during pregnancy: A Vaccine Safety Datalink study.

Groom HC, Smith N, Irving SA, Koppolu P, Vazquez-Benitez G, Kharbanda EO, Daley MF, Donahue JG, Getahun D, Jackson LA, Klein NP, McCarthy NL, Nordin JD, Panagiotakopoulos L, Naleway AL.

Vaccine. 2019 Oct 16;37(44):6648-6655. doi: 10.1016/j.vaccine.2019.09.043. Epub 2019 Sep 20.

PMID:
31548013
4.

Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15.

Donahue JG, Kieke BA, King JP, Mascola MA, Shimabukuro TT, DeStefano F, Hanson KE, McClure DL, Olaiya O, Glanz JM, Hechter RC, Irving SA, Jackson LA, Klein NP, Naleway AL, Weintraub ES, Belongia EA.

Vaccine. 2019 Oct 16;37(44):6673-6681. doi: 10.1016/j.vaccine.2019.09.035. Epub 2019 Sep 17.

5.

Incidence of Herpes Zoster Among Children: 2003-2014.

Weinmann S, Naleway AL, Koppolu P, Baxter R, Belongia EA, Hambidge SJ, Irving SA, Jackson ML, Klein NP, Lewin B, Liles E, Marin M, Smith N, Weintraub E, Chun C.

Pediatrics. 2019 Jul;144(1). pii: e20182917. doi: 10.1542/peds.2018-2917. Epub 2019 Jun 10.

PMID:
31182552
6.

Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination.

Markowitz LE, Naleway AL, Lewis RM, Crane B, Querec TD, Weinmann S, Steinau M, Unger ER.

Vaccine. 2019 Jun 27;37(29):3918-3924. doi: 10.1016/j.vaccine.2019.04.099. Epub 2019 May 31.

PMID:
31160099
7.

Factors associated with recruitment, surveillance participation, and retention in an observational study of pregnant women and influenza.

Thompson MG, Li DK, Naleway AL, Ferber JR, Henninger ML, Shifflett P, Sokolow LZ, Odouli R, Kauffman TL, Fink RV, Bulkley J, Cragan JD, Bozeman S.

BMC Pregnancy Childbirth. 2019 May 8;19(1):161. doi: 10.1186/s12884-019-2280-0.

8.

Estimating Vaccine Effectiveness Against Hospitalized Influenza During Pregnancy: Multicountry Protocol for a Retrospective Cohort Study.

Naleway AL, Ball S, Kwong JC, Wyant BE, Katz MA, Regan AK, Russell ML, Klein NP, Chung H, Simmonds KA, Azziz-Baumgartner E, Feldman BS, Levy A, Fell DB, Drews SJ, Garg S, Effler P, Barda N, Irving SA, Shifflett P, Jackson ML, Thompson MG.

JMIR Res Protoc. 2019 Jan 21;8(1):e11333. doi: 10.2196/11333.

9.

Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disorders.

McClure DL, Jacobsen SJ, Klein NP, Naleway AL, Kharbanda EO, Glanz JM, Jackson LA, Weintraub ES, McLean HQ.

Vaccine. 2019 Jan 3;37(1):76-79. doi: 10.1016/j.vaccine.2018.11.038. Epub 2018 Nov 23.

10.

Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study.

Groom HC, Irving SA, Koppolu P, Smith N, Vazquez-Benitez G, Kharbanda EO, Daley MF, Donahue JG, Getahun D, Jackson LA, Tse Kawai A, Klein NP, McCarthy NL, Nordin JD, Sukumaran L, Naleway AL.

Vaccine. 2018 Oct 1;36(41):6111-6116. doi: 10.1016/j.vaccine.2018.08.074. Epub 2018 Sep 5.

11.

Primary Ovarian Insufficiency and Adolescent Vaccination.

Naleway AL, Mittendorf KF, Irving SA, Henninger ML, Crane B, Smith N, Daley MF, Gee J.

Pediatrics. 2018 Sep;142(3). pii: e20180943. doi: 10.1542/peds.2018-0943. Epub 2018 Aug 21.

12.

A model for rapid, active surveillance for medically-attended acute gastroenteritis within an integrated health care delivery system.

Schmidt MA, Groom HC, Naleway AL, Biggs C, Salas SB, Shioda K, Marsh Z, Donald JL, Hall AJ.

PLoS One. 2018 Aug 3;13(8):e0201805. doi: 10.1371/journal.pone.0201805. eCollection 2018.

13.

Risk of Spontaneous Abortion After Inadvertent Human Papillomavirus Vaccination in Pregnancy.

Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Sheth SS, Zhu J, Naleway AL, Klein NP, Hechter R, Daley MF, Donahue JG, Jackson ML, Kawai AT, Sukumaran L, Nordin JD.

Obstet Gynecol. 2018 Jul;132(1):35-44. doi: 10.1097/AOG.0000000000002694.

14.

Feasibility of a pilot intervention to reduce pain and syncope during adolescent vaccination.

Henninger ML, Kuntz JL, Firemark AJ, Varga AM, Bok K, Naleway AL.

Vaccine. 2018 Jun 22;36(27):3937-3942. doi: 10.1016/j.vaccine.2018.05.070. Epub 2018 May 24.

PMID:
29805090
15.

Human Papillomavirus Vaccine Coverage and Prevalence of Missed Opportunities for Vaccination in an Integrated Healthcare System.

Irving SA, Groom HC, Stokley S, McNeil MM, Gee J, Smith N, Naleway AL.

Acad Pediatr. 2018 Mar;18(2S):S85-S92. doi: 10.1016/j.acap.2017.09.002.

16.

Infant Hospitalizations and Mortality After Maternal Vaccination.

Sukumaran L, McCarthy NL, Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Jackson L, Klein NP, Naleway AL, McClure DL, Hechter RC, Kawai AT, Glanz JM, Weintraub ES.

Pediatrics. 2018 Mar;141(3). pii: e20173310. doi: 10.1542/peds.2017-3310. Epub 2018 Feb 20.

17.

Myocarditis and pericarditis are rare following live viral vaccinations in adults.

Kuntz J, Crane B, Weinmann S, Naleway AL; Vaccine Safety Datalink Investigator Team.

Vaccine. 2018 Mar 14;36(12):1524-1527. doi: 10.1016/j.vaccine.2018.02.030. Epub 2018 Feb 15.

18.

Rates and risk factors associated with hospitalization for pneumonia with ICU admission among adults.

Storms AD, Chen J, Jackson LA, Nordin JD, Naleway AL, Glanz JM, Jacobsen SJ, Weintraub ES, Klein NP, Gargiullo PM, Fry AM.

BMC Pulm Med. 2017 Dec 16;17(1):208. doi: 10.1186/s12890-017-0552-x.

19.

The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study.

Daley MF, Clarke CL, Glanz JM, Xu S, Hambidge SJ, Donahue JG, Nordin JD, Klein NP, Jacobsen SJ, Naleway AL, Jackson ML, Lee G, Duffy J, Weintraub E.

Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):59-68. doi: 10.1002/pds.4349. Epub 2017 Nov 17.

20.

Dental provider practices and perceptions regarding adolescent vaccination.

Naleway AL, Henninger ML, Waiwaiole LA, Mosen DM, Leo MC, Pihlstrom DJ.

J Public Health Dent. 2018 Mar;78(2):159-164. doi: 10.1111/jphd.12256. Epub 2017 Nov 8.

PMID:
29114884
21.

2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States.

Poehling KA, Caspard H, Peters TR, Belongia EA, Congeni B, Gaglani M, Griffin MR, Irving SA, Kavathekar PK, McLean HQ, Naleway AL, Ryan K, Talbot HK, Ambrose CS.

Clin Infect Dis. 2018 Feb 10;66(5):665-672. doi: 10.1093/cid/cix869.

22.

Estimated rates of influenza-associated outpatient visits during 2001-2010 in 6 US integrated healthcare delivery organizations.

Zhou H, Thompson WW, Belongia EA, Fowlkes A, Baxter R, Jacobsen SJ, Jackson ML, Glanz JM, Naleway AL, Ford DC, Weintraub E, Shay DK.

Influenza Other Respir Viruses. 2018 Jan;12(1):122-131. doi: 10.1111/irv.12495. Epub 2018 Feb 15.

23.

Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12.

Donahue JG, Kieke BA, King JP, DeStefano F, Mascola MA, Irving SA, Cheetham TC, Glanz JM, Jackson LA, Klein NP, Naleway AL, Weintraub E, Belongia EA.

Vaccine. 2017 Sep 25;35(40):5314-5322. doi: 10.1016/j.vaccine.2017.06.069.

24.

User-Centered Design for Developing Interventions to Improve Clinician Recommendation of Human Papillomavirus Vaccination.

Henninger ML, Mcmullen CK, Firemark AJ, Naleway AL, Henrikson NB, Turcotte JA.

Perm J. 2017;21:16-191. doi: 10.7812/TPP/16-191.

25.

Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink.

Vickers ER, McClure DL, Naleway AL, Jacobsen SJ, Klein NP, Glanz JM, Weintraub ES, Belongia EA.

Vaccine. 2017 Oct 13;35(43):5872-5877. doi: 10.1016/j.vaccine.2017.08.086. Epub 2017 Sep 6.

26.

Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy.

Lipkind HS, Vazquez-Benitez G, Nordin JD, Romitti PA, Naleway AL, Klein NP, Hechter RC, Jackson ML, Hambidge SJ, Lee GM, Sukumaran L, Kharbanda EO.

Obstet Gynecol. 2017 Sep;130(3):599-608. doi: 10.1097/AOG.0000000000002191.

27.

Human Papillomavirus Vaccine Effectiveness Against Incident Genital Warts Among Female Health-Plan Enrollees, United States.

Hariri S, Schuler MS, Naleway AL, Daley MF, Weinmann S, Crane B, Newcomer SR, Tolsma D, Markowitz LE.

Am J Epidemiol. 2018 Feb 1;187(2):298-305. doi: 10.1093/aje/kwx253.

PMID:
28641366
28.

Maternal Tdap vaccination and risk of infant morbidity.

DeSilva M, Vazquez-Benitez G, Nordin JD, Lipkind HS, Klein NP, Cheetham TC, Naleway AL, Hambidge SJ, Lee GM, Jackson ML, McCarthy NL, Kharbanda EO.

Vaccine. 2017 Jun 22;35(29):3655-3660. doi: 10.1016/j.vaccine.2017.05.041. Epub 2017 May 25.

29.

First Trimester Influenza Vaccination and Risks for Major Structural Birth Defects in Offspring.

Kharbanda EO, Vazquez-Benitez G, Romitti PA, Naleway AL, Cheetham TC, Lipkind HS, Klein NP, Lee G, Jackson ML, Hambidge SJ, McCarthy N, DeStefano F, Nordin JD; Vaccine Safety Datalink.

J Pediatr. 2017 Aug;187:234-239.e4. doi: 10.1016/j.jpeds.2017.04.039. Epub 2017 May 24.

30.

Predictors of Breastfeeding Initiation and Maintenance in an Integrated Healthcare Setting.

Henninger ML, Irving SA, Kauffman TL, Kurosky SK, Rompala K, Thompson MG, Sokolow LZ, Avalos LA, Ball SW, Shifflett P, Naleway AL; Pregnancy and Influenza Project Workgroup.

J Hum Lact. 2017 May;33(2):256-266. doi: 10.1177/0890334417695202. Epub 2017 Mar 23.

PMID:
28418800
31.

Live attenuated influenza vaccine use and safety in children and adults with asthma.

Duffy J, Lewis M, Harrington T, Baxter R, Belongia EA, Jackson LA, Jacobsen SJ, Lee GM, Naleway AL, Nordin J, Daley MF; Vaccine Safety Datalink.

Ann Allergy Asthma Immunol. 2017 Apr;118(4):439-444. doi: 10.1016/j.anai.2017.01.030.

32.

Implementing a Multipartner HPV Vaccination Assessment and Feedback Intervention in an Integrated Health System.

Groom HC, Irving SA, Caldwell J, Larsen R, Beaudrault S, Luther LM, Naleway AL.

J Public Health Manag Pract. 2017 Nov/Dec;23(6):589-592. doi: 10.1097/PHH.0000000000000562.

PMID:
28257408
33.

Identifying birth defects in automated data sources in the Vaccine Safety Datalink.

Kharbanda EO, Vazquez-Benitez G, Romitti PA, Naleway AL, Cheetham TC, Lipkind HS, Sivanandam S, Klein NP, Lee GM, Jackson ML, Hambidge SJ, Olsen A, McCarthy N, DeStefano F, Nordin JD.

Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):412-420. doi: 10.1002/pds.4153. Epub 2017 Jan 4.

34.

Acute Demyelinating Events Following Vaccines: A Case-Centered Analysis.

Baxter R, Lewis E, Goddard K, Fireman B, Bakshi N, DeStefano F, Gee J, Tseng HF, Naleway AL, Klein NP.

Clin Infect Dis. 2016 Dec 1;63(11):1456-1462. Epub 2016 Sep 1.

35.

Risk of Preterm or Small-for-Gestational-Age Birth After Influenza Vaccination During Pregnancy: Caveats When Conducting Retrospective Observational Studies.

Vazquez-Benitez G, Kharbanda EO, Naleway AL, Lipkind H, Sukumaran L, McCarthy NL, Omer SB, Qian L, Xu S, Jackson ML, Vijayadev V, Klein NP, Nordin JD.

Am J Epidemiol. 2016 Aug 1;184(3):176-86. doi: 10.1093/aje/kww043. Epub 2016 Jul 22.

36.

Reduced serologic sensitivity to influenza A virus illness among inactivated influenza vaccinees.

Thompson MG, Gaglani MJ, Naleway AL, Dowell SH, Spencer S, Ball S, Levine M, Fry A.

Vaccine. 2016 Jun 24;34(30):3443-6. doi: 10.1016/j.vaccine.2016.04.085. Epub 2016 May 16.

PMID:
27195761
37.

Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013.

Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Klein NP, Cheetham TC, Naleway AL, Lee GM, Hambidge S, Jackson ML, Omer SB, McCarthy N, Nordin JD.

Vaccine. 2016 Feb 10;34(7):968-73. doi: 10.1016/j.vaccine.2015.12.046. Epub 2016 Jan 4.

38.

Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008-2011.

Naleway AL, Crane B, Smith N, Daley MF, Donahue J, Gee J, Greene SK, Harrington T, Jackson LA, Klein NP, Tseng HF, Vellozzi C, Weintraub ES; Vaccine Safety Datalink.

Vaccine. 2016 Jan 2;34(1):167-71. doi: 10.1016/j.vaccine.2015.10.006. Epub 2015 Nov 6.

39.

Influenza Vaccination During Pregnancy: Influenza Seasons 2002-2012, Vaccine Safety Datalink.

Groom HC, Henninger ML, Smith N, Koppolu P, Cheetham TC, Glanz JM, Hambidge SJ, Jackson LA, Kharbanda EO, Klein NP, McCarthy NL, Nordin JD, Weintraub ES, Naleway AL.

Am J Prev Med. 2016 Apr;50(4):480-488. doi: 10.1016/j.amepre.2015.08.017. Epub 2015 Oct 31.

PMID:
26526159
40.

Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children.

Glanz JM, Newcomer SR, Daley MF, McClure DL, Baxter RP, Jackson ML, Naleway AL, Lugg MM, DeStefano F.

Vaccine. 2015 Nov 27;33(48):6736-44. doi: 10.1016/j.vaccine.2015.10.076. Epub 2015 Oct 27.

PMID:
26518400
41.

Association of Tdap Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing Immunizations.

Sukumaran L, McCarthy NL, Kharbanda EO, McNeil MM, Naleway AL, Klein NP, Jackson ML, Hambidge SJ, Lugg MM, Li R, Weintraub ES, Bednarczyk RA, King JP, DeStefano F, Orenstein WA, Omer SB.

JAMA. 2015 Oct 20;314(15):1581-7. doi: 10.1001/jama.2015.12790.

42.

Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis and Influenza Vaccinations in Pregnancy.

Sukumaran L, McCarthy NL, Kharbanda EO, Weintraub ES, Vazquez-Benitez G, McNeil MM, Li R, Klein NP, Hambidge SJ, Naleway AL, Lugg MM, Jackson ML, King JP, DeStefano F, Omer SB, Orenstein WA.

Obstet Gynecol. 2015 Nov;126(5):1069-74. doi: 10.1097/AOG.0000000000001066.

43.

Demographic characteristics of members of the Vaccine Safety Datalink (VSD): A comparison with the United States population.

Sukumaran L, McCarthy NL, Li R, Weintraub ES, Jacobsen SJ, Hambidge SJ, Jackson LA, Naleway AL, Chan B, Tao B, Gee J.

Vaccine. 2015 Aug 26;33(36):4446-50. doi: 10.1016/j.vaccine.2015.07.037. Epub 2015 Jul 23.

44.

Risk of Herpes Zoster and Disseminated Varicella Zoster in Patients Taking Immunosuppressant Drugs at the Time of Zoster Vaccination.

Cheetham TC, Marcy SM, Tseng HF, Sy LS, Liu IL, Bixler F, Baxter R, Donahue JG, Naleway AL, Jacobsen SJ.

Mayo Clin Proc. 2015 Jul;90(7):865-73. doi: 10.1016/j.mayocp.2015.04.021. Epub 2015 Jun 4.

PMID:
26051268
45.

Factors associated with seasonal influenza vaccination in pregnant women.

Henninger ML, Irving SA, Thompson M, Avalos LA, Ball SW, Shifflett P, Naleway AL; Influenza Project (PIP) Working Group.

J Womens Health (Larchmt). 2015 May;24(5):394-402. doi: 10.1089/jwh.2014.5105. Epub 2015 Apr 15.

46.

Results of a pilot study using self-collected mid-turbinate nasal swabs for detection of influenza virus infection among pregnant women.

Thompson MG, Ferber JR, Odouli R, David D, Shifflett P, Meece JK, Naleway AL, Bozeman S, Spencer SM, Fry AM, Li DK.

Influenza Other Respir Viruses. 2015 May;9(3):155-60. doi: 10.1111/irv.12309.

47.

Pregnancy after treatment for cervical cancer precursor lesions in a retrospective matched cohort.

Naleway AL, Weinmann S, Krishnarajah G, Arondekar B, Fernandez J, Swamy G, Myers E.

PLoS One. 2015 Feb 11;10(2):e0117525. doi: 10.1371/journal.pone.0117525. eCollection 2015.

48.

The association between influenza vaccination and other preventative health behaviors in a cohort of pregnant women.

Scheminske M, Henninger M, Irving SA, Thompson M, Williams J, Shifflett P, Ball SW, Avalos LA, Naleway AL; Pregnancy and Influenza Project Workgroup.

Health Educ Behav. 2015 Jun;42(3):402-8. doi: 10.1177/1090198114560021. Epub 2014 Dec 12.

PMID:
25504630
49.

Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006.

Abrams JY, Weintraub ES, Baggs JM, McCarthy NL, Schonberger LB, Lee GM, Klein NP, Belongia EA, Jackson ML, Naleway AL, Nordin JD, Hambidge SJ, Belay ED.

Vaccine. 2015 Jan 3;33(2):382-7. doi: 10.1016/j.vaccine.2014.10.044. Epub 2014 Nov 4.

PMID:
25444786
50.

Severity of influenza and noninfluenza acute respiratory illness among pregnant women, 2010-2012.

Sokolow LZ, Naleway AL, Li DK, Shifflett P, Reynolds S, Henninger ML, Ferber JR, Odouli R, Irving SA, Thompson MG; Pregnancy and Influenza Project Workgroup.

Am J Obstet Gynecol. 2015 Feb;212(2):202.e1-11. doi: 10.1016/j.ajog.2014.08.004. Epub 2014 Aug 8.

Supplemental Content

Loading ...
Support Center